Search

Your search keyword '"Servas, Véronique"' showing total 2 results
Start Over Author "Servas, Véronique" Topic french guiana
2 results on '"Servas, Véronique"'

1. Outbreak of Oropouche Virus in French Guiana.

Author

Gaillet, Mélanie, Pichard, Clara, Restrepo, Johana, Lavergne, Anne, Perez, Lucas, Enfissi, Antoine, Abboud, Philippe, Lambert, Yann, Ma, Laurence, Monot, Marc, Demar, Magalie, Djossou, Felix, Servas, Véronique, Nacher, Mathieu, Andrieu, Audrey, Prudhomme, Julie, Michaud, Céline, Rousseau, Cyril, Jeanne, Isabelle, and Duchemin, Jean-Bernard

Subjects
VIRUSES, RAIN forests, FEVER, ARBOVIRUSES, BUNYAVIRUSES
Abstract

Oropouche fever is a zoonotic dengue-like syndrome caused by Oropouche virus. In August-September 2020, dengue-like syndrome developed in 41 patients in a remote rainforest village in French Guiana. By PCR or microneutralization, 23 (82.1%) of 28 tested patients were positive for Oropouche virus, documenting its emergence in French Guiana. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

2. Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020

Author

Flamand, Claude, Alves Sarmento, Christelle, Enfissi, Antoine, Bailly, Sarah, Beillard, Emmanuel, Gaillet, Mélanie, Michaud, Céline, Servas, Véronique, Clement, Nathalie, Perilhou, Anaïs, Carage, Thierry, Musso, Didier, Carod, Jean-François, Eustache, Stéphanie, Tourbillon, Céline, Boizon, Elodie, James, Samantha, Djossou, Félix, Salje, Henrik, Cauchemez, Simon, and Rousset, Dominique

Subjects
Adult, Aged, 80 and over, Adolescent, SARS-CoV-2, COVID-19, Infant, Middle Aged, Antibodies, Viral, 3. Good health, French Guiana, Young Adult, Cross-Sectional Studies, Seroepidemiologic Studies, Child, Preschool, Immunoglobulin G, Humans, Child, Aged
Abstract

Funder: National Research Agency, Funder: Regional Health Agency of French Guiana, Funder: Institut Pasteur Urgence COVID-19 fundraising, BACKGROUND: While Latin America has been heavily affected by the pandemic, only a few seroprevalence studies have been conducted there during the first epidemic wave in the first half of 2020. METHODOLOGY/PRINCIPAL FINDINGS: A cross-sectional survey was performed between 15 July 2020 and 23 July 2020 among individuals who visited 4 medical laboratories or 5 health centers for routine screening or clinical management, with the exception of symptomatic suggestive cases of covid-19. Samples were screened for the presence of anti-SARS-CoV-2 IgG directed against domain S1 of the SARS-CoV-2 spike protein using the anti-SARS-CoV-2 enzyme-linked immunosorbent assay (ELISA) from Euroimmun. CONCLUSIONS/SIGNIFICANCE: The overall seroprevalence was 15.4% [9.3%-24.4%] among 480 participants, ranging from 4.0% to 25.5% across the different municipalities. The seroprevalence did not differ according to gender (p = 0.19) or age (p = 0.51). Among SARS-CoV-2 positive individuals, we found that 24.6% [11.5%-45.2%] reported symptoms consistent with COVID-19. Our findings revealed high levels of infection across the territory but a low number of resulting deaths, which can be explained by French Guiana's young population structure.

Catalog

Books, media, physical & digital resources
See catalog results